A randomized trial of deep-brain stimulation for Parkinson's disease G Deuschl, C Schade-Brittinger, P Krack, J Volkmann, H Schäfer, K Bötzel, ... New England Journal of Medicine 355 (9), 896-908, 2006 | 3276 | 2006 |
Neurostimulation for Parkinson's disease with early motor complications WMM Schuepbach, J Rau, K Knudsen, J Volkmann, P Krack, ... New England Journal of Medicine 368 (7), 610-622, 2013 | 1514 | 2013 |
Pallidal deep-brain stimulation in primary generalized or segmental dystonia A Kupsch, R Benecke, J Müller, T Trottenberg, GH Schneider, W Poewe, ... New England Journal of Medicine 355 (19), 1978-1990, 2006 | 1111 | 2006 |
Reduction in subthalamic 8–35 Hz oscillatory activity correlates with clinical improvement in Parkinson's disease AA Kühn, A Kupsch, GH Schneider, P Brown European Journal of Neuroscience 23 (7), 1956-1960, 2006 | 907 | 2006 |
High-frequency stimulation of the subthalamic nucleus suppresses oscillatory β activity in patients with Parkinson's disease in parallel with improvement in motor performance AA Kühn, F Kempf, C Brücke, LG Doyle, I Martinez-Torres, A Pogosyan, ... Journal of Neuroscience 28 (24), 6165-6173, 2008 | 898 | 2008 |
Event‐related beta desynchronization in human subthalamic nucleus correlates with motor performance AA Kühn, D Williams, A Kupsch, P Limousin, M Hariz, GH Schneider, ... Brain 127 (4), 735-746, 2004 | 840 | 2004 |
Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study K Witt, C Daniels, J Reiff, P Krack, J Volkmann, MO Pinsker, M Krause, ... The Lancet Neurology 7 (7), 605-614, 2008 | 757 | 2008 |
Pathological synchronisation in the subthalamic nucleus of patients with Parkinson's disease relates to both bradykinesia and rigidity AA Kühn, A Tsui, T Aziz, N Ray, C Brücke, A Kupsch, GH Schneider, ... Experimental neurology 215 (2), 380-387, 2009 | 641 | 2009 |
Connectivity predicts deep brain stimulation outcome in P arkinson disease A Horn, M Reich, J Vorwerk, N Li, G Wenzel, Q Fang, T Schmitz‐Hübsch, ... Annals of neurology 82 (1), 67-78, 2017 | 596 | 2017 |
The relationship between local field potential and neuronal discharge in the subthalamic nucleus of patients with Parkinson's disease AA Kühn, T Trottenberg, A Kivi, A Kupsch, GH Schneider, P Brown Experimental neurology 194 (1), 212-220, 2005 | 466 | 2005 |
Patterning of globus pallidus local field potentials differs between Parkinson’s disease and dystonia P Silberstein, AA KuÈhn, A Kupsch, T Trottenberg, JK Krauss, JC WoÈhrle, ... Brain 126 (12), 2597-2608, 2003 | 445 | 2003 |
Dopamine depletion increases the power and coherence of β‐oscillations in the cerebral cortex and subthalamic nucleus of the awake rat A Sharott, PJ Magill, D Harnack, A Kupsch, W Meissner, P Brown European Journal of Neuroscience 21 (5), 1413-1422, 2005 | 432 | 2005 |
Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells A Storch, G Paul, M Csete, BO Boehm, PM Carvey, A Kupsch, J Schwarz Experimental neurology 170 (2), 317-325, 2001 | 396 | 2001 |
Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial J Volkmann, A Wolters, A Kupsch, J Müller, AA Kühn, GH Schneider, ... The Lancet Neurology 11 (12), 1029-1038, 2012 | 373 | 2012 |
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease P Brundin, O Pogarell, P Hagell, P Piccini, H Widner, A Schrag, A Kupsch, ... Brain 123 (7), 1380-1390, 2000 | 372 | 2000 |
Cortico-cortical coupling in Parkinson's disease and its modulation by therapy P Silberstein, A Pogosyan, AA Kühn, G Hotton, S Tisch, A Kupsch, ... Brain 128 (6), 1277-1291, 2005 | 358 | 2005 |
Comparing exercise in Parkinson's disease—the Berlin BIG Study G Ebersbach, A Ebersbach, D Edler, O Kaufhold, M Kusch, A Kupsch, ... Movement disorders 25 (12), 1902-1908, 2010 | 353 | 2010 |
Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial J Volkmann, J Mueller, G Deuschl, AA Kühn, JK Krauss, W Poewe, ... The Lancet Neurology 13 (9), 875-884, 2014 | 329 | 2014 |
A phase 2 trial of the GSK‐3 inhibitor tideglusib in progressive supranuclear palsy E Tolosa, I Litvan, GU Höglinger, D Burn, A Lees, MV Andrés, ... Movement Disorders 29 (4), 470-478, 2014 | 315 | 2014 |
Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q10 in Parkinson disease A Storch, WH Jost, P Vieregge, J Spiegel, W Greulich, J Durner, T Müller, ... Archives of neurology 64 (7), 938-944, 2007 | 274 | 2007 |